Nickel in PDB 6xvw: Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050
Enzymatic activity of Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050
All present enzymatic activity of Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050:
2.4.2.30;
Protein crystallography data
The structure of Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050, PDB code: 6xvw
was solved by
J.Pfahler,
C.Steegborn,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
71.73 /
2.00
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
68.172,
86.727,
127.635,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
23 /
26.5
|
Nickel Binding Sites:
The binding sites of Nickel atom in the Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050
(pdb code 6xvw). This binding sites where shown within
5.0 Angstroms radius around Nickel atom.
In total 6 binding sites of Nickel where determined in the
Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050, PDB code: 6xvw:
Jump to Nickel binding site number:
1;
2;
3;
4;
5;
6;
Nickel binding site 1 out
of 6 in 6xvw
Go back to
Nickel Binding Sites List in 6xvw
Nickel binding site 1 out
of 6 in the Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050
Mono view
Stereo pair view
|
A full contact list of Nickel with other atoms in the Ni binding
site number 1 of Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ni1101
b:49.3
occ:1.00
|
O
|
B:HOH1251
|
2.0
|
54.7
|
1.0
|
NE2
|
B:HIS937
|
2.0
|
36.4
|
1.0
|
NE2
|
A:HIS934
|
2.1
|
43.7
|
1.0
|
O
|
B:HOH1306
|
2.2
|
37.0
|
1.0
|
O
|
B:HOH1269
|
2.2
|
44.2
|
1.0
|
O
|
B:HOH1254
|
2.4
|
45.3
|
1.0
|
CE1
|
B:HIS937
|
3.0
|
37.1
|
1.0
|
CE1
|
A:HIS934
|
3.0
|
43.2
|
1.0
|
CD2
|
B:HIS937
|
3.1
|
36.3
|
1.0
|
CD2
|
A:HIS934
|
3.1
|
40.6
|
1.0
|
O
|
B:HOH1334
|
3.6
|
75.4
|
1.0
|
O
|
A:HOH1361
|
3.7
|
62.1
|
1.0
|
OG
|
A:SER936
|
4.0
|
54.5
|
1.0
|
ND1
|
B:HIS937
|
4.1
|
37.7
|
1.0
|
ND1
|
A:HIS934
|
4.1
|
40.5
|
1.0
|
O
|
B:THR887
|
4.2
|
45.2
|
1.0
|
CG
|
B:HIS937
|
4.2
|
38.8
|
1.0
|
CG
|
A:HIS934
|
4.2
|
39.3
|
1.0
|
OD1
|
B:ASP756
|
4.4
|
93.4
|
1.0
|
O
|
A:ALA935
|
4.6
|
45.9
|
1.0
|
CB
|
B:THR887
|
4.7
|
46.9
|
1.0
|
O
|
A:HOH1380
|
4.8
|
54.5
|
1.0
|
CG
|
B:ASP756
|
5.0
|
90.5
|
1.0
|
|
Nickel binding site 2 out
of 6 in 6xvw
Go back to
Nickel Binding Sites List in 6xvw
Nickel binding site 2 out
of 6 in the Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050
Mono view
Stereo pair view
|
A full contact list of Nickel with other atoms in the Ni binding
site number 2 of Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ni1102
b:50.5
occ:1.00
|
NE2
|
A:HIS937
|
2.0
|
40.1
|
1.0
|
NE2
|
B:HIS934
|
2.0
|
35.5
|
1.0
|
O
|
A:HOH1261
|
2.1
|
60.6
|
1.0
|
O
|
B:HOH1237
|
2.1
|
63.3
|
1.0
|
O
|
A:HOH1341
|
2.4
|
51.0
|
1.0
|
O
|
A:HOH1264
|
2.4
|
51.4
|
1.0
|
CE1
|
A:HIS937
|
2.9
|
38.8
|
1.0
|
CE1
|
B:HIS934
|
3.0
|
36.2
|
1.0
|
CD2
|
B:HIS934
|
3.0
|
33.9
|
1.0
|
CD2
|
A:HIS937
|
3.1
|
40.1
|
1.0
|
O
|
B:HOH1328
|
3.4
|
54.9
|
1.0
|
O
|
A:HOH1255
|
3.8
|
49.3
|
1.0
|
OG
|
B:SER936
|
3.9
|
53.2
|
1.0
|
ND1
|
A:HIS937
|
4.0
|
39.5
|
1.0
|
ND1
|
B:HIS934
|
4.1
|
35.4
|
1.0
|
CG
|
B:HIS934
|
4.2
|
34.6
|
1.0
|
O
|
A:THR887
|
4.2
|
41.4
|
1.0
|
CG
|
A:HIS937
|
4.2
|
40.9
|
1.0
|
OD1
|
A:ASP756
|
4.4
|
73.8
|
1.0
|
O
|
B:ALA935
|
4.5
|
43.3
|
1.0
|
O
|
A:HOH1379
|
4.5
|
44.2
|
1.0
|
CB
|
A:THR887
|
4.8
|
38.9
|
1.0
|
|
Nickel binding site 3 out
of 6 in 6xvw
Go back to
Nickel Binding Sites List in 6xvw
Nickel binding site 3 out
of 6 in the Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050
Mono view
Stereo pair view
|
A full contact list of Nickel with other atoms in the Ni binding
site number 3 of Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ni1103
b:78.5
occ:1.00
|
O
|
B:HOH1202
|
1.9
|
67.5
|
1.0
|
NE2
|
A:HIS909
|
1.9
|
47.0
|
1.0
|
O
|
A:HOH1339
|
2.5
|
55.0
|
1.0
|
O
|
A:HOH1322
|
2.6
|
47.6
|
1.0
|
CE1
|
A:HIS909
|
2.7
|
49.5
|
1.0
|
O
|
B:HOH1326
|
2.8
|
60.0
|
1.0
|
O
|
A:HOH1350
|
2.8
|
52.7
|
1.0
|
CD2
|
A:HIS909
|
3.1
|
47.4
|
1.0
|
OD1
|
B:ASP981
|
3.6
|
0.8
|
1.0
|
O
|
A:HOH1310
|
3.7
|
51.2
|
1.0
|
ND1
|
A:HIS909
|
3.9
|
46.4
|
1.0
|
CG
|
A:HIS909
|
4.1
|
44.9
|
1.0
|
OD2
|
B:ASP981
|
4.3
|
0.8
|
1.0
|
CG
|
B:ASP981
|
4.4
|
0.8
|
1.0
|
OE1
|
A:GLU763
|
4.5
|
96.7
|
1.0
|
O
|
A:HOH1204
|
4.7
|
65.5
|
1.0
|
O
|
B:HOH1342
|
4.8
|
54.4
|
1.0
|
O
|
A:HOH1234
|
4.8
|
43.2
|
1.0
|
OE2
|
A:GLU763
|
4.8
|
0.4
|
1.0
|
O
|
A:HOH1312
|
5.0
|
55.0
|
1.0
|
|
Nickel binding site 4 out
of 6 in 6xvw
Go back to
Nickel Binding Sites List in 6xvw
Nickel binding site 4 out
of 6 in the Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050
Mono view
Stereo pair view
|
A full contact list of Nickel with other atoms in the Ni binding
site number 4 of Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ni1104
b:49.6
occ:1.00
|
NE2
|
A:HIS826
|
2.1
|
41.2
|
1.0
|
O
|
A:HOH1222
|
2.1
|
44.5
|
1.0
|
NE2
|
A:HIS822
|
2.1
|
37.5
|
1.0
|
OD1
|
A:ASP830
|
2.2
|
46.0
|
1.0
|
O
|
A:HOH1356
|
2.2
|
45.6
|
1.0
|
O
|
A:HOH1317
|
2.3
|
41.0
|
1.0
|
CE1
|
A:HIS822
|
2.9
|
37.6
|
1.0
|
CE1
|
A:HIS826
|
2.9
|
42.0
|
1.0
|
CG
|
A:ASP830
|
3.1
|
45.3
|
1.0
|
CD2
|
A:HIS826
|
3.2
|
40.7
|
1.0
|
CD2
|
A:HIS822
|
3.3
|
36.8
|
1.0
|
OD2
|
A:ASP830
|
3.3
|
46.8
|
1.0
|
O
|
A:HOH1390
|
3.4
|
56.1
|
1.0
|
O
|
A:HOH1285
|
3.9
|
43.8
|
1.0
|
ND1
|
A:HIS822
|
4.1
|
38.1
|
1.0
|
ND1
|
A:HIS826
|
4.1
|
42.2
|
1.0
|
CG
|
A:HIS826
|
4.2
|
41.9
|
1.0
|
CG
|
A:HIS822
|
4.3
|
37.4
|
1.0
|
CB
|
A:ASP830
|
4.4
|
43.5
|
1.0
|
N
|
A:LEU831
|
4.5
|
44.1
|
1.0
|
O
|
A:LEU831
|
4.7
|
46.9
|
1.0
|
CA
|
A:ASP830
|
4.7
|
42.1
|
1.0
|
CE
|
A:LYS819
|
4.9
|
68.6
|
1.0
|
NZ
|
A:LYS819
|
4.9
|
71.0
|
1.0
|
|
Nickel binding site 5 out
of 6 in 6xvw
Go back to
Nickel Binding Sites List in 6xvw
Nickel binding site 5 out
of 6 in the Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050
Mono view
Stereo pair view
|
A full contact list of Nickel with other atoms in the Ni binding
site number 5 of Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ni1101
b:79.8
occ:1.00
|
NE2
|
B:HIS909
|
2.0
|
41.1
|
1.0
|
O
|
A:HOH1207
|
2.0
|
87.1
|
1.0
|
O
|
B:HOH1320
|
2.4
|
65.1
|
1.0
|
O
|
B:HOH1289
|
2.4
|
47.8
|
1.0
|
O
|
B:HOH1299
|
2.7
|
78.3
|
1.0
|
CE1
|
B:HIS909
|
2.8
|
39.5
|
1.0
|
O
|
B:HOH1268
|
2.9
|
62.2
|
1.0
|
O
|
A:HOH1298
|
3.1
|
54.0
|
1.0
|
CD2
|
B:HIS909
|
3.2
|
40.3
|
1.0
|
O
|
B:HOH1347
|
3.7
|
56.5
|
1.0
|
O
|
A:HOH1358
|
3.7
|
89.9
|
1.0
|
O
|
B:HOH1227
|
3.9
|
56.5
|
1.0
|
ND1
|
B:HIS909
|
3.9
|
37.8
|
1.0
|
OD1
|
A:ASP981
|
4.0
|
0.1
|
1.0
|
OE2
|
B:GLU763
|
4.0
|
71.9
|
1.0
|
CG
|
B:HIS909
|
4.2
|
39.1
|
1.0
|
ND2
|
A:ASN980
|
4.4
|
95.4
|
1.0
|
O
|
B:HOH1345
|
4.6
|
73.6
|
1.0
|
CD
|
B:GLU763
|
5.0
|
69.1
|
1.0
|
|
Nickel binding site 6 out
of 6 in 6xvw
Go back to
Nickel Binding Sites List in 6xvw
Nickel binding site 6 out
of 6 in the Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050
Mono view
Stereo pair view
|
A full contact list of Nickel with other atoms in the Ni binding
site number 6 of Catalytic Domain of Human Parp-1 in Complex with the Inhibitor MC2050 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ni1102
b:75.9
occ:1.00
|
NE2
|
B:HIS822
|
2.1
|
50.7
|
1.0
|
O
|
B:HOH1222
|
2.1
|
50.4
|
1.0
|
O
|
B:HOH1305
|
2.2
|
68.2
|
1.0
|
NE2
|
B:HIS826
|
2.3
|
55.1
|
1.0
|
O
|
B:HOH1217
|
2.3
|
49.0
|
1.0
|
OD1
|
B:ASP830
|
2.4
|
64.9
|
1.0
|
CE1
|
B:HIS822
|
2.7
|
51.4
|
1.0
|
CE1
|
B:HIS826
|
3.1
|
54.2
|
1.0
|
CG
|
B:ASP830
|
3.3
|
61.3
|
1.0
|
CD2
|
B:HIS822
|
3.3
|
51.3
|
1.0
|
CD2
|
B:HIS826
|
3.4
|
53.7
|
1.0
|
O
|
B:HOH1343
|
3.5
|
66.8
|
1.0
|
OD2
|
B:ASP830
|
3.5
|
62.8
|
1.0
|
NZ
|
B:LYS819
|
3.8
|
68.3
|
1.0
|
ND1
|
B:HIS822
|
3.9
|
50.5
|
1.0
|
O
|
B:HOH1308
|
4.0
|
57.1
|
1.0
|
CD
|
B:LYS819
|
4.2
|
64.4
|
1.0
|
CG
|
B:HIS822
|
4.3
|
50.2
|
1.0
|
ND1
|
B:HIS826
|
4.3
|
51.9
|
1.0
|
CG
|
B:HIS826
|
4.5
|
52.2
|
1.0
|
O
|
B:HOH1341
|
4.6
|
58.7
|
1.0
|
CB
|
B:ASP830
|
4.7
|
59.7
|
1.0
|
CE
|
B:LYS819
|
4.7
|
66.3
|
1.0
|
N
|
B:LEU831
|
4.7
|
51.4
|
1.0
|
O
|
B:LEU831
|
4.8
|
50.5
|
1.0
|
CA
|
B:ASP830
|
4.9
|
55.6
|
1.0
|
|
Reference:
S.Tomassi,
J.Pfahler,
N.Mautone,
A.Rovere,
C.Esposito,
D.Passeri,
R.Pellicciari,
E.Novellino,
M.Pannek,
C.Steegborn,
A.Paiardini,
A.Mai,
D.Rotili.
From PARP1 to TNKS2 Inhibition: A Structure-Based Approach. Acs Med.Chem.Lett. V. 11 862 2020.
ISSN: ISSN 1948-5875
PubMed: 32435397
DOI: 10.1021/ACSMEDCHEMLETT.9B00654
Page generated: Thu Oct 10 08:59:21 2024
|